ENDRA Life Sciences Inc.

NASDAQ: NDRAHealthcare / Medical Instruments & Supplies / -
1.45+0.0200+1.40%Vol 32 0441Y Perf -46.54%
Aug 20th, 2019 16:00
BID1.36 ASK1.43
Open1.42 Previous Close1.43
Pre-Market- After-Trading-
 - -%  - -%
Target Price
5.50 
Analyst Rating
Strong Buy 1.33
Potencial %
279.31 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)10 
Earnings Rating
Neutral
Price Range Ratio 52wk %
11.34 
Earnings Date
12th Aug 2019

Today's Price Range

1.341.45

52wk Range

0.90005.75

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
4.32%
1 Month
-0.68%
3 Months
20.83%
6 Months
-20.33%
1 Year
-46.54%
3 Years
-
5 Years
-
10 Years
-

Name / TickerPriceChg.Chg.%
NDRA1.450.02001.40
AAPL210.610.26000.12
GOOG1 182.69-15.7600-1.32
MSFT137.26-1.1500-0.83
XOM69.03-0.4200-0.60
WFC44.68-0.5700-1.26
JNJ130.60-1.6500-1.25
FB183.81-2.3600-1.27
GE8.38-0.2900-3.34
JPM107.31-1.3800-1.27
Earnings HistoryEstimateReportedSurprise %
Q02 2019-0.28-0.31-10.71
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
9/2019 QR-0.19--
12/2019 QR-0.13--
12/2019 FY-1.04--
12/2020 FY-0.71--
Next Report Date-
Estimated EPS Next Report-0.28
Estimates Count2
EPS Growth Next 5 Years %30.00
Volume Overview
Volume32 044
Shares Outstanding (in ths.)6 630
Trades Count277
Dollar Volume149 409
Avg. Volume207 658
Avg. Weekly Volume33 943
Avg. Monthly Volume59 706
Avg. Quarterly Volume116 224
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
0
Moderate Buy
1 (33.33 %)
1 (33.33 %)
0
Hold
0 (0.00 %)
0 (0.00 %)
0
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0
Strong Sell
0 (0.00 %)
0 (0.00 %)
0
RatingStrong Buy
1.33
Strong Buy
1.33
-

ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc develops diagnostics and research products supported by ultrasound technology in the United States. Its products are used in various applications to enhance the audible performance of the ultrasound technology in medical devices. ENDRA's products are applied for varied purposes including the Nexus 128 pre-clinical and Thermo-Acoustic Enhanced Ultrasound clinical applications such as molecular probe uptake, quantitative tumor imaging, hepatic steatosis and vessel imaging.

CEO: Francois Michelon

Teplephone: +1 734 335-0468

Address: 3600 Green Court, Ann Arbor 48105-1570, MI, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

38%63%

Bearish Bullish

58%42%

Bearish Bullish

43%57%

News